U.S. Markets
CVS (CVS) adds Lilly’s (LLY) Zepbound to its preferred drug list in a reversal of prior stance, Bloomberg reports
Related stocks
2 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
